O	0	19	Immunohistochemical	Immunohistochemical	JJ	B-NP
O	20	28	analysis	analysis	NN	I-NP
O	29	31	of	of	IN	B-PP
O	32	36	nm23	nm23	NN	B-NP
O	36	37	-	-	HYPH	B-NP
O	37	39	H1	H1	NN	I-NP
O	40	44	gene	gene	NN	I-NP
O	45	52	product	product	NN	I-NP
O	53	55	in	in	IN	B-PP
B-Multi-tissue_structure	56	60	node	node	NN	B-NP
O	60	61	-	-	HYPH	B-NP
O	61	69	positive	positive	JJ	I-NP
B-Cancer	70	74	lung	lung	NN	I-NP
I-Cancer	75	81	cancer	cancer	NN	I-NP
O	82	85	and	and	CC	I-NP
B-Multi-tissue_structure	86	91	lymph	lymph	NN	I-NP
I-Multi-tissue_structure	92	97	nodes	node	NNS	I-NP
O	97	98	.	.	.	O

O	100	103	The	The	DT	B-NP
O	104	108	nm23	nm23	NN	I-NP
O	108	109	-	-	HYPH	I-NP
O	109	111	H1	H1	NN	I-NP
O	112	116	gene	gene	NN	I-NP
O	117	124	product	product	NN	I-NP
O	125	128	has	have	VBZ	B-VP
O	129	133	been	be	VBN	I-VP
O	134	144	considered	consider	VBN	I-VP
O	145	147	as	as	IN	B-PP
O	148	150	an	an	DT	B-NP
O	151	155	anti	anti	AFX	I-NP
O	155	156	-	-	HYPH	I-NP
O	156	166	metastatic	metastatic	JJ	I-NP
O	167	174	protein	protein	NN	I-NP
O	175	178	and	and	CC	O
O	179	182	the	the	DT	B-NP
O	183	188	level	level	NN	I-NP
O	189	191	of	of	IN	B-PP
O	192	195	its	its	PRP$	B-NP
O	196	206	expression	expression	NN	I-NP
O	207	210	has	have	VBZ	B-VP
O	211	215	been	be	VBN	I-VP
O	216	224	reported	report	VBN	I-VP
O	225	227	to	to	TO	I-VP
O	228	237	correlate	correlate	VB	I-VP
O	238	247	inversely	inversely	RB	B-ADVP
O	248	252	with	with	IN	B-PP
O	253	263	metastatic	metastatic	JJ	B-NP
O	264	273	potential	potential	NN	I-NP
O	274	276	in	in	IN	B-PP
O	277	281	some	some	DT	B-NP
B-Cancer	282	289	cancers	cancer	NNS	I-NP
O	289	290	.	.	.	O

O	291	298	However	However	RB	B-ADVP
O	298	299	,	,	,	O
O	300	303	the	the	DT	B-NP
O	304	314	expression	expression	NN	I-NP
O	315	317	of	of	IN	B-PP
O	318	322	nm23	nm23	NN	B-NP
O	322	323	-	-	HYPH	B-NP
O	323	325	H1	H1	NN	I-NP
O	326	330	gene	gene	NN	I-NP
O	331	338	product	product	NN	I-NP
O	339	341	in	in	IN	B-PP
O	342	345	the	the	DT	B-NP
B-Cancer	346	356	metastatic	metastatic	JJ	I-NP
I-Cancer	357	362	sites	site	NNS	I-NP
O	363	367	have	have	VBP	B-VP
O	368	371	not	not	RB	I-VP
O	372	376	been	be	VBN	I-VP
O	377	384	studied	study	VBN	I-VP
O	385	387	in	in	IN	B-PP
O	388	394	detail	detail	NN	B-NP
O	394	395	.	.	.	O

O	396	398	We	We	PRP	B-NP
O	399	407	examined	examine	VBD	B-VP
O	408	411	the	the	DT	B-NP
O	412	422	expression	expression	NN	I-NP
O	423	425	of	of	IN	B-PP
O	426	430	nm23	nm23	NN	B-NP
O	430	431	-	-	HYPH	B-NP
O	431	433	H1	H1	NN	I-NP
O	434	438	gene	gene	NN	I-NP
O	439	446	product	product	NN	I-NP
O	447	449	in	in	IN	B-PP
O	450	460	surgically	surgically	RB	B-NP
O	461	469	resected	resecte	VBN	I-NP
O	470	472	46	46	CD	B-NP
O	473	478	pairs	pair	NNS	I-NP
O	479	481	of	of	IN	B-PP
B-Cancer	482	489	primary	primary	JJ	B-NP
I-Cancer	490	494	lung	lung	NN	I-NP
I-Cancer	495	502	cancers	cancer	NNS	I-NP
O	503	506	and	and	CC	O
B-Multi-tissue_structure	507	517	metastatic	metastatic	JJ	B-NP
I-Multi-tissue_structure	518	523	lymph	lymph	NN	I-NP
I-Multi-tissue_structure	524	529	nodes	node	NNS	I-NP
O	530	532	by	by	IN	B-PP
O	533	553	immunohistochemistry	immunohistochemistry	NN	B-NP
O	553	554	.	.	.	O

O	555	558	The	The	DT	B-NP
O	559	567	positive	positive	JJ	I-NP
O	568	576	staining	staining	NN	I-NP
O	577	579	of	of	IN	B-PP
O	580	584	nm23	nm23	NN	B-NP
O	584	585	-	-	HYPH	B-NP
O	585	587	H1	H1	NN	I-NP
O	588	592	gene	gene	NN	I-NP
O	593	600	product	product	NN	I-NP
O	601	603	in	in	IN	B-PP
B-Cancer	604	611	primary	primary	JJ	B-NP
I-Cancer	612	619	cancers	cancer	NNS	I-NP
O	620	623	and	and	CC	O
B-Multi-tissue_structure	624	634	metastatic	metastatic	JJ	B-NP
I-Multi-tissue_structure	635	640	lymph	lymph	NN	I-NP
I-Multi-tissue_structure	641	646	nodes	node	NNS	I-NP
O	647	651	were	be	VBD	B-VP
O	652	660	observed	observe	VBN	I-VP
O	661	663	in	in	IN	B-PP
O	664	666	56	56	CD	B-NP
O	666	667	.	.	.	O
O	667	668	5	5	CD	B-NP
O	669	672	and	and	CC	I-NP
O	673	675	67	67	CD	I-NP
O	675	676	.	.	.	O
O	676	677	4	4	CD	B-NP
O	677	678	%	%	NN	I-NP
O	678	679	,	,	,	O
O	680	692	respectively	respectively	RB	B-ADVP
O	692	693	.	.	.	O

O	694	697	The	The	DT	B-NP
O	698	711	heterogeneity	heterogeneity	NN	I-NP
O	712	714	of	of	IN	B-PP
O	715	719	nm23	nm23	NN	B-NP
O	719	720	-	-	HYPH	B-NP
O	720	722	H1	H1	NN	I-NP
O	723	727	gene	gene	NN	I-NP
O	728	735	product	product	NN	I-NP
O	736	746	expression	expression	NN	I-NP
O	747	754	between	between	IN	B-PP
B-Cancer	755	762	primary	primary	JJ	B-NP
I-Cancer	763	770	cancers	cancer	NNS	I-NP
O	771	774	and	and	CC	O
B-Multi-tissue_structure	775	785	metastatic	metastatic	JJ	B-NP
I-Multi-tissue_structure	786	791	lymph	lymph	NN	I-NP
I-Multi-tissue_structure	792	797	nodes	node	NNS	I-NP
O	798	801	was	be	VBD	B-VP
O	802	810	observed	observe	VBN	I-VP
O	811	813	in	in	IN	B-PP
O	814	816	41	41	CD	B-NP
O	816	817	.	.	.	O
O	817	818	3	3	CD	B-NP
O	818	819	%	%	NN	I-NP
O	819	820	.	.	.	O

O	821	823	No	No	DT	B-NP
O	824	836	correlations	correlation	NNS	I-NP
O	837	841	were	be	VBD	B-VP
O	842	847	found	find	VBN	I-VP
O	848	855	between	between	IN	B-PP
O	856	859	the	the	DT	B-NP
O	860	864	nm23	nm23	NN	I-NP
O	864	865	-	-	HYPH	B-NP
O	865	867	H1	H1	NN	I-NP
O	868	872	gene	gene	NN	I-NP
O	873	880	product	product	NN	I-NP
O	881	891	expression	expression	NN	I-NP
O	892	894	in	in	IN	B-PP
B-Cancer	895	899	lung	lung	NN	B-NP
I-Cancer	900	907	cancers	cancer	NNS	I-NP
O	908	911	and	and	CC	O
O	912	915	the	the	DT	B-NP
O	916	924	patients	patient	NNS	I-NP
O	925	933	survival	survival	NN	I-NP
O	933	934	.	.	.	O

O	935	937	No	No	DT	B-NP
O	938	949	significant	significant	JJ	I-NP
O	950	961	association	association	NN	I-NP
O	962	965	was	be	VBD	B-VP
O	966	970	also	also	RB	I-VP
O	971	979	observed	observe	VBN	I-VP
O	980	987	between	between	IN	B-PP
O	988	992	nm23	nm23	NN	B-NP
O	992	993	-	-	HYPH	I-NP
O	993	995	H1	H1	NN	I-NP
O	996	1000	gene	gene	NN	I-NP
O	1001	1008	product	product	NN	I-NP
O	1009	1019	expression	expression	NN	I-NP
O	1020	1022	in	in	IN	B-PP
B-Multi-tissue_structure	1023	1028	lymph	lymph	NN	B-NP
I-Multi-tissue_structure	1029	1034	nodes	node	NNS	I-NP
O	1035	1038	and	and	CC	O
O	1039	1042	the	the	DT	B-NP
O	1043	1051	patients	patient	NNS	I-NP
O	1052	1060	survival	survival	NN	I-NP
O	1060	1061	.	.	.	O

O	1062	1067	There	There	EX	B-NP
O	1068	1071	was	be	VBD	B-VP
O	1071	1072	,	,	,	O
O	1073	1084	furthermore	furthermore	RB	B-ADVP
O	1084	1085	,	,	,	O
O	1086	1088	no	no	DT	B-NP
O	1089	1100	correlation	correlation	NN	I-NP
O	1101	1108	between	between	IN	B-PP
O	1109	1112	the	the	DT	B-NP
O	1113	1126	heterogeneity	heterogeneity	NN	I-NP
O	1127	1129	of	of	IN	B-PP
O	1130	1134	nm23	nm23	NN	B-NP
O	1134	1135	-	-	HYPH	B-NP
O	1135	1137	H1	H1	NN	I-NP
O	1138	1142	gene	gene	NN	I-NP
O	1143	1150	product	product	NN	I-NP
O	1151	1161	expression	expression	NN	I-NP
O	1162	1165	and	and	CC	O
O	1166	1169	the	the	DT	B-NP
O	1170	1178	patients	patient	NNS	I-NP
O	1179	1187	survival	survival	NN	I-NP
O	1187	1188	.	.	.	O

O	1189	1191	In	In	IN	B-PP
O	1192	1202	conclusion	conclusion	NN	B-NP
O	1202	1203	,	,	,	O
O	1204	1207	the	the	DT	B-NP
O	1208	1213	level	level	NN	I-NP
O	1214	1216	of	of	IN	B-PP
O	1217	1221	nm23	nm23	NN	B-NP
O	1221	1222	-	-	HYPH	I-NP
O	1222	1224	H1	H1	NN	I-NP
O	1225	1229	gene	gene	NN	I-NP
O	1230	1237	product	product	NN	I-NP
O	1238	1248	expression	expression	NN	I-NP
O	1249	1253	does	do	VBZ	B-VP
O	1254	1257	not	not	RB	I-VP
O	1258	1271	significantly	significantly	RB	I-VP
O	1272	1278	reveal	reveal	VB	I-VP
O	1279	1289	prognostic	prognostic	JJ	B-NP
O	1290	1295	value	value	NN	I-NP
O	1296	1298	in	in	IN	B-PP
B-Multi-tissue_structure	1299	1303	node	node	NN	B-NP
O	1303	1304	-	-	HYPH	B-NP
O	1304	1312	positive	positive	JJ	I-NP
B-Cancer	1313	1317	lung	lung	NN	I-NP
I-Cancer	1318	1325	cancers	cancer	NNS	I-NP
O	1325	1326	.	.	.	O

O	1327	1337	Expression	Expression	NN	B-NP
O	1338	1340	of	of	IN	B-PP
O	1341	1345	nm23	nm23	NN	B-NP
O	1345	1346	-	-	HYPH	B-NP
O	1346	1348	H1	H1	NN	I-NP
O	1349	1353	gene	gene	NN	I-NP
O	1354	1361	product	product	NN	I-NP
O	1362	1364	in	in	IN	B-PP
B-Multi-tissue_structure	1365	1375	metastatic	metastatic	JJ	B-NP
I-Multi-tissue_structure	1376	1381	lymph	lymph	NN	I-NP
I-Multi-tissue_structure	1382	1387	nodes	node	NNS	I-NP
O	1388	1391	was	be	VBD	B-VP
O	1392	1396	also	also	RB	B-ADVP
O	1397	1406	unrelated	unrelated	JJ	B-ADJP
O	1407	1409	to	to	TO	B-PP
O	1410	1418	patients	patient	NNS	B-NP
O	1419	1427	survival	survival	NN	I-NP
O	1427	1428	.	.	.	O

